DuChemBIO Co.,Ltd. (XKON:A176750) announced a private placement of 300,000 convertible preferred shares for aggregate gross proceeds of KRW 3,000,000,000 on July 5, 2018. The transaction will include participation from 2017KF-Smilegate Singularity Fund for 200,000 shares and Haemil Asset Management Financial Limited for 100,000 shares. The securities have a face value of KRW 500 per unit which will be issued at premium value of KRW 10000 each. The preferred stock is convertible into common shares of the company and the conversion period is from July 14, 2018 to July 14, 2028. The payment date is July 13, 2018. The transaction has been approved by the board of directors of the company.